School of Medicine 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Lima, Peru.
CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
BMJ Open. 2022 Mar 15;12(3):e058921. doi: 10.1136/bmjopen-2021-058921.
To summarise available chronic kidney disease (CKD) diagnostic and prognostic models in low-income and middle-income countries (LMICs).
Systematic review (Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines). We searched Medline, EMBASE, Global Health (these three through OVID), Scopus and Web of Science from inception to 9 April 2021, 17 April 2021 and 18 April 2021, respectively. We first screened titles and abstracts, and then studied in detail the selected reports; both phases were conducted by two reviewers independently. We followed the CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies recommendations and used the Prediction model Risk Of Bias ASsessment Tool for risk of bias assessment.
The search retrieved 14 845 results, 11 reports were studied in detail and 9 (n=61 134) were included in the qualitative analysis. The proportion of women in the study population varied between 24.5% and 76.6%, and the mean age ranged between 41.8 and 57.7 years. Prevalence of undiagnosed CKD ranged between 1.1% and 29.7%. Age, diabetes mellitus and sex were the most common predictors in the diagnostic and prognostic models. Outcome definition varied greatly, mostly consisting of urinary albumin-to-creatinine ratio and estimated glomerular filtration rate. The highest performance metric was the negative predictive value. All studies exhibited high risk of bias, and some had methodological limitations.
There is no strong evidence to support the use of a CKD diagnostic or prognostic model throughout LMIC. The development, validation and implementation of risk scores must be a research and public health priority in LMIC to enhance CKD screening to improve timely diagnosis.
总结中低收入国家(LMICs)现有的慢性肾脏病(CKD)诊断和预后模型。
系统评价(系统评价和荟萃分析报告的首选项目指南)。我们分别通过 OVID 搜索了 Medline、EMBASE、Global Health(这三个数据库)、Scopus 和 Web of Science,从创建到 2021 年 4 月 9 日、2021 年 4 月 17 日和 2021 年 4 月 18 日。我们首先筛选标题和摘要,然后详细研究选定的报告;这两个阶段都是由两位评审员独立进行的。我们遵循预测模型研究的关键评估和数据提取清单建议,并使用预测模型风险偏倚评估工具进行风险偏倚评估。
搜索共检索到 14845 条结果,详细研究了 11 份报告,纳入了 9 份(n=61134)进行定性分析。研究人群中女性的比例在 24.5%至 76.6%之间,平均年龄在 41.8 至 57.7 岁之间。未确诊 CKD 的患病率在 1.1%至 29.7%之间。年龄、糖尿病和性别是诊断和预后模型中最常见的预测因素。结局定义差异很大,主要包括尿白蛋白与肌酐比值和估计肾小球滤过率。最高的性能指标是阴性预测值。所有研究均显示出高风险偏倚,部分研究存在方法学局限性。
没有强有力的证据支持在整个 LMIC 中使用 CKD 诊断或预后模型。在 LMIC 中,风险评分的开发、验证和实施必须成为研究和公共卫生的重点,以加强 CKD 筛查,提高及时诊断。